NCT00025662
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +31 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
1,801 public trials
304 recruiting studies
Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results
Completed
Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study)
NCT00015587
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Acute Myelogenous Leukemia, +13 more
- Locations
-
- University of California, School of Public Health, Childhood Leukemia Study Berkeley, California, United States
NCT00862719
- Conditions
- Acute Lymphoblastic Leukemia, Anemia, Anemia, Refractory, +26 more
- Locations
-
- IU Simon Cancer Center Indianapolis, Indiana, United States
NCT00047164
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +33 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
NCT01331590
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT01527838
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Chronic Disease, +26 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program Boston, Massachusetts, United States
- Ohio State Univeristy Comprehensive Cancer Center Columbus, Ohio, United States
NCT02888990
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Cliniques Universitaires Saint-Luc Brussels, Belgium
- CHU Ambroise Paré Mons, Belgium
- Centre Hospitalier Départemental FELIX GUYON Saint-Denis, La Reunion, France
- Ch D'Aix En Provence Aix-en-Provence, France
Completed
Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia
NCT01826214
- Conditions
- Acute Leukemias, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- Duke University Medical Center SC-5 Durham, North Carolina, United States
- Novartis Investigative Site Adelaide, South Australia, Australia
- Novartis Investigative Site Prahran, Victoria, Australia
- Novartis Investigative Site Salzburg, Austria
Completed
Effect of Enteral Docosahexaenoic Acid Administration in Children With Acute Lymphoblastic Leukemia
NCT01051154
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Unit of Research in Nutrition, Pediatric Hospital, Instituto Mexicano del Seguro Social Mexico City, Mexico
NCT00642031
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +24 more
- Locations
-
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- UT MD Anderson Cancer Center Houston, Texas, United States